◆英語タイトル:Refocus Group Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010123
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Refocus Group Inc (Refocus Group) is a medical equipment company that concentrates on research and development of treatments for human vision disorders. The company has developed visability implant system (VIS) for the treatment of presbyopia. Its VIS procedure is an outpatient procedure that involves implantation. It VIS implants provides treatment for presbyopia that restores natural ability to focus at near and intermediate distances. The implants are designed for focusing that muscles work better to improve near vision. It offers various surgical options for treatment that offers maintains cornea and lens integrity and others. It markets products in the US and Canada. Refocus Group is headquartered at Dallas, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Refocus Group Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Refocus Group Inc Company Overview 4
Refocus Group Inc Company Snapshot 4
Refocus Group Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Refocus Group Inc – Pipeline Analysis Overview 7
Refocus Group Inc – Key Facts 7
Refocus Group Inc – Major Products and Services 8
Refocus Group Inc Pipeline Products by Development Stage 9
Refocus Group Inc Ongoing Clinical Trials by Trial Status 11
Refocus Group Inc Pipeline Products Overview 13
PresVIEW Scleral Implant – Glaucoma 13
PresVIEW Scleral Implant – Glaucoma Product Overview 13
PresVIEW Scleral Implant – Presbyopia 14
PresVIEW Scleral Implant – Presbyopia Product Overview 14
VisAbility Implant System 15
VisAbility Implant System Product Overview 15
VisAbility Implant System Clinical Trial 16
Refocus Group Inc – Key Competitors 17
Refocus Group Inc – Key Employees 18
Refocus Group Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Refocus Group Inc, Recent Developments 20
May 05, 2016: Refocus Group Completes Phase 3 Clinical Trial on the VisAbility Micro-Insert System for Presbyopia; Raises Additional Funding 20
Appendix 22
Methodology 22
About GlobalData 24
Contact Us 24
Disclaimer 25
List of Tables
Refocus Group Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Refocus Group Inc Pipeline Products by Equipment Type 5
Refocus Group Inc Pipeline Products by Indication 6
Refocus Group Inc Ongoing Clinical Trials by Trial Status 6
Refocus Group Inc, Key Facts 7
Refocus Group Inc, Major Products and Services 8
Refocus Group Inc Number of Pipeline Products by Development Stage 9
Refocus Group Inc Pipeline Products Summary by Development Stage 10
Refocus Group Inc Ongoing Clinical Trials by Trial Status 11
Refocus Group Inc Ongoing Clinical Trials Summary 12
PresVIEW Scleral Implant - Glaucoma - Product Status 13
PresVIEW Scleral Implant - Glaucoma - Product Description 13
PresVIEW Scleral Implant - Presbyopia - Product Status 14
PresVIEW Scleral Implant - Presbyopia - Product Description 14
VisAbility Implant System - Product Status 15
VisAbility Implant System - Product Description 15
VisAbility Implant System - A Prospective, Multicenter Clinical Trial of the VisAbility Implant System for Improvement of Near Visual Acuity in Presbyopic Patients 16
Refocus Group Inc, Key Employees 18
Glossary 23